Prelude Capital Management’s Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share LGV.WS Stock Holding History

Prelude Capital Management's LGV.WS Position: Q4 2022 in Review

Prelude Capital Management sold out of Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share (LGV.WS) in Q4 2022, closing a stake of 47,690 shares — an estimated $3K sold.

Prelude Capital Management first reported a position in LGV.WS in Q1 2022 and held it in 3 quarters. The position peaked at $20K in Q1 2022. 0 funds tracked by Wall St. Rank hold LGV.WS as of Q4 2022.

• Prelude Capital Management reported no remaining Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
• Prelude Capital Management sold 47,690 Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share shares in Q4 2022, an estimated $3K.
• Prelude Capital Management first reported a position in Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share in Q1 2022 and held it in 3 quarters.
• Prelude Capital Management's Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position peaked at $20K in Q1 2022.
• 0 funds tracked by Wall St. Rank held Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.